{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:34:21Z","timestamp":1785198861835,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["R01DK077073"],"award-info":[{"award-number":["R01DK077073"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["R01DK090035"],"award-info":[{"award-number":["R01DK090035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["R01DK101637"],"award-info":[{"award-number":["R01DK101637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["K01DK096127"],"award-info":[{"award-number":["K01DK096127"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["VA CDA-2\u20141 IK2 BX001942"],"award-info":[{"award-number":["VA CDA-2\u20141 IK2 BX001942"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["T32DK007545"],"award-info":[{"award-number":["T32DK007545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.trsl.2014.06.004","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T21:00:58Z","timestamp":1403038858000},"page":"499-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The proteinuria\u2014hypertriglyceridemia connection as a basis for novel therapeutics for nephrotic syndrome"],"prefix":"10.1016","volume":"165","author":[{"given":"Lionel C.","family":"Clement","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Mac\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-1423","authenticated-orcid":false,"given":"Maria","family":"Del Nogal Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline B.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumant S.","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2014.06.004_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.ajkd.2011.07.024","article-title":"New insights into human minimal change disease: lessons from animal models","volume":"59","author":"Chugh","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trsl.2014.06.004_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/74166","article-title":"NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome","volume":"24","author":"Boute","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2014.06.004_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI200318242","article-title":"Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability","volume":"112","author":"Liu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2014.06.004_bib4","doi-asserted-by":"crossref","first-page":"39681","DOI":"10.1074\/jbc.M606664200","article-title":"ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome","volume":"281","author":"Liu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2014.06.004_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nm.2602","article-title":"Telomerase at the center of collapsing glomerulopathy","volume":"18","author":"Chugh","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2014.06.004_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte- secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2014.06.004_bib7","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1097\/01.ASN.0000102671.77794.33","article-title":"Edema in the nephrotic syndrome: new aspect of an old enigma","volume":"14","author":"Hamm","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2014.06.004_bib8","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1046\/j.1523-1755.2003.00941.x","article-title":"Molecular mechanisms of lipid disorders in nephrotic syndrome","volume":"63","author":"Vaziri","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2014.06.004_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","article-title":"Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome","volume":"20","author":"Clement","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2014.06.004_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ng1984","article-title":"Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL","volume":"39","author":"Romeo","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2014.06.004_bib11","doi-asserted-by":"crossref","first-page":"28488","DOI":"10.1074\/jbc.M004029200","article-title":"Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene","volume":"275","author":"Kersten","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2014.06.004_bib12","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1128\/MCB.20.14.5343-5349.2000","article-title":"Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation","volume":"20","author":"Yoon","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2014.06.004_bib13","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.108.182147","article-title":"Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids","volume":"29","author":"Kersten","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2014.06.004_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2337\/db07-1438","article-title":"Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans","volume":"58","author":"Staiger","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2014.06.004_bib15","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCRESAHA.110.217380","article-title":"Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta\/delta and protects against fatty acid-induced oxidative stress","volume":"106","author":"Georgiadi","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2014.06.004_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ki.1987.243","article-title":"Characterization of cationic albumin in minimal change nephropathy","volume":"32","author":"Ghiggeri","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2014.06.004_bib17","doi-asserted-by":"crossref","first-page":"25593","DOI":"10.1074\/jbc.M109.025452","article-title":"Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism","volume":"284","author":"Koliwad","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2014.06.004_bib18","doi-asserted-by":"crossref","first-page":"13213","DOI":"10.1074\/jbc.M900553200","article-title":"Genetic variation in ANGPTL4 provides insights into protein processing and function","volume":"284","author":"Yin","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2014.06.004_bib19","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2215\/CJN.01450214","article-title":"Glomerular disease: seeing beyond pathology","volume":"9","author":"Wiggins","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2014.06.004_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fphar.2014.00023","article-title":"Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease","volume":"5","author":"Chugh","year":"2014","journal-title":"Front Pharmacol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524414002102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524414002102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T04:58:36Z","timestamp":1538542716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524414002102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1931524414002102"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2014.06.004","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The proteinuria\u2014hypertriglyceridemia connection as a basis for novel therapeutics for nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2014.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}